Following 2 μg/mL TM plus 120 nM GSK2606414 treatment for 48 h, we found a significant decrease in P-PERK, P-eIF2α, ATF4 and CHOP levels in X-ALD fibroblasts. This evidence concerns the gene EIF2A and X-linked adrenoleukodystrophy.